Recommended antimicrobial treatment of uncomplicated gonorrhoea in 2009 in 11 East European countries: Implementation of a Neisseria gonorrhoeae antimicrobial susceptibility programme in this region is crucial

Sexually Transmitted Infections

Volumn 86, Issue 6, 2010, Pages 442-444

  Unemo, Magnus ^a   Shipitsyna, E ^b   Domeika, M ^c  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b D O OTT RESEARCH INSTITUTE OF OBSTETRICS   (Russian Federation)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; KANAMYCIN; OFLOXACIN; ROXITHROMYCIN; SPECTINOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; DRUG SURVEILLANCE PROGRAM; EUROPE; EVIDENCE BASED MEDICINE; GEOGRAPHIC DISTRIBUTION; GONORRHEA; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; NONHUMAN; PRIORITY JOURNAL; QUESTIONNAIRE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPE, EASTERN; GONORRHEA; HEALTH POLICY; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; POPULATION SURVEILLANCE; QUESTIONNAIRES;

EID: 78449242759     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2010.042317     Document Type: Article

References (11)

1. Schmid G. World Health Organization (WHO) 2005 global estimates of the incidence and prevalence of sexually transmitted infections (STIs). WHO/CDC symposium: congenital syphilis and the 2005 WHO estimates of STI incidence and prevalence: using the second to help eliminate the first. 18th International Society for Sexually Transmitted Disease Research conference (ISSTDR). London, 2009.
2. WHO web site Gonorrhoea - Incidence rate (per 100,000 population). Published by World Health Organization Regional Office for Europe. Centralized information system for infectious diseases (CISID)/Sexually transmitted infections (STI). http://data.euro.who.int/cisid.
3. Tapsall JW, Ndowa F, Lewis D, et al. Meeting the public health challenge of multi-and extensively-drug resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2009;7:821-34.
4. Tapsall JW. Antimicrobial resistance in Neisseria gonorrhoeae WHO/CDS/CSR/DRS/ 2001.3. Geneva: World Health Organization, 2001. http://www.who.int/entity/ drugresistance/Antimicrobial-resistance-in-Neisseria- gonorrhoeae.pdf.
5. Martin IMC, Hoffman S, Ison CA. European surveillance of sexually transmitted infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrobial Chemother 2006;58:587-93.
6. Roy K, Wang SA, Meltzer MI. Optimizing treatment of antimicrobial resistant Neisseria gonorrhoeae. Emerg Infect Dis 2005;11:1265-73. (Pubitemid 41045336)
7. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother 2009; 10:555-77.
8. Unemo M, Fasth O, Fredlund H, et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 2009;63: 1142-51.
9. Kubanova A, Frigo N, Kubanov A, et al. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendation of first-line antimicrobials for gonorrhoea treatment in Russia. Sex Transm Infect 2008;84:285-9.
10. WHO Collaborating Centre for STD. Rationale and applications for the current (2008) WHO panel of Neisseria gonorrhoeae for antimicrobial resistance surveillance for public health purposes, and instructions for their use. Technical document D007-0408-1#1. Sydney, 2008.
11. Domeika M, Savicheva A, Sokolovskiy E, et al. Eastern European Network for Sexual and Reproductive Health (EE SRH Network). Quality enhancements and quality assurance of laboratory diagnosis of sexually transmitted infections in Eastern Europe. Int J STD AIDS 2009;20:365-7.